- Home
- IMAX vs CLDX Comparison
IMAX vs CLDX Comparison
Compare IMAX & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAX
- CLDX
- Stock Information
- Founded
- IMAX 1967
- CLDX N/A
- Country
- IMAX Canada
- CLDX United States
- Employees
- IMAX N/A
- CLDX N/A
- Industry
- IMAX
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- IMAX
- CLDX Health Care
- Exchange
- IMAX Nasdaq
- CLDX Nasdaq
- Market Cap
- IMAX 1.3B
- CLDX 1.6B
- IPO Year
- IMAX 1994
- CLDX 2008
- Fundamental
- Price
- IMAX $32.36
- CLDX $24.45
- Analyst Decision
- IMAX Strong Buy
- CLDX Strong Buy
- Analyst Count
- IMAX 9
- CLDX 9
- Target Price
- IMAX $32.44
- CLDX $46.13
- AVG Volume (30 Days)
- IMAX 1.1M
- CLDX 1.6M
- Earning Date
- IMAX 10-29-2025
- CLDX 11-05-2025
- Dividend Yield
- IMAX N/A
- CLDX N/A
- EPS Growth
- IMAX 52.36
- CLDX N/A
- EPS
- IMAX 0.60
- CLDX N/A
- Revenue
- IMAX $362,475,000.00
- CLDX $5,790,000.00
- Revenue This Year
- IMAX $16.96
- CLDX N/A
- Revenue Next Year
- IMAX $5.72
- CLDX N/A
- P/E Ratio
- IMAX $54.17
- CLDX N/A
- Revenue Growth
- IMAX 1.25
- CLDX N/A
- 52 Week Low
- IMAX $18.76
- CLDX $14.40
- 52 Week High
- IMAX $32.36
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- IMAX 80.08
- CLDX 57.32
- Support Level
- IMAX $28.42
- CLDX $22.44
- Resistance Level
- IMAX $31.37
- CLDX $25.51
- Average True Range (ATR)
- IMAX 0.86
- CLDX 1.22
- MACD
- IMAX 0.41
- CLDX 0.23
- Stochastic Oscillator
- IMAX 99.91
- CLDX 74.58
About IMAX Imax Corporation
Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.